nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—VCAM1—periodontitis	0.646	0.816	CbGaD
Carvedilol—ADRB1—periodontitis	0.146	0.184	CbGaD
Carvedilol—GJA1—periosteum—periodontitis	0.0095	0.105	CbGeAlD
Carvedilol—VCAM1—tongue—periodontitis	0.00431	0.0475	CbGeAlD
Carvedilol—SELE—endothelium—periodontitis	0.00408	0.045	CbGeAlD
Carvedilol—VCAM1—endothelium—periodontitis	0.00375	0.0414	CbGeAlD
Carvedilol—HIF1A—endothelium—periodontitis	0.00361	0.0398	CbGeAlD
Carvedilol—GJA1—endothelium—periodontitis	0.0035	0.0386	CbGeAlD
Carvedilol—VCAM1—mouth—periodontitis	0.0029	0.0319	CbGeAlD
Carvedilol—HIF1A—mouth—periodontitis	0.00279	0.0307	CbGeAlD
Carvedilol—GJA1—mouth—periodontitis	0.0027	0.0298	CbGeAlD
Carvedilol—VCAM1—neck—periodontitis	0.00248	0.0273	CbGeAlD
Carvedilol—HIF1A—neck—periodontitis	0.00238	0.0263	CbGeAlD
Carvedilol—NDUFC2—mouth—periodontitis	0.00235	0.0259	CbGeAlD
Carvedilol—SELE—trigeminal ganglion—periodontitis	0.00232	0.0256	CbGeAlD
Carvedilol—GJA1—neck—periodontitis	0.00231	0.0255	CbGeAlD
Carvedilol—VCAM1—trigeminal ganglion—periodontitis	0.00214	0.0236	CbGeAlD
Carvedilol—HIF1A—trigeminal ganglion—periodontitis	0.00206	0.0227	CbGeAlD
Carvedilol—VCAM1—parotid gland—periodontitis	0.00202	0.0222	CbGeAlD
Carvedilol—NDUFC2—neck—periodontitis	0.00201	0.0222	CbGeAlD
Carvedilol—GJA1—trigeminal ganglion—periodontitis	0.002	0.022	CbGeAlD
Carvedilol—HIF1A—parotid gland—periodontitis	0.00194	0.0214	CbGeAlD
Carvedilol—SELE—connective tissue—periodontitis	0.00193	0.0213	CbGeAlD
Carvedilol—GJA1—parotid gland—periodontitis	0.00188	0.0207	CbGeAlD
Carvedilol—SELE—epithelium—periodontitis	0.00183	0.0202	CbGeAlD
Carvedilol—VCAM1—connective tissue—periodontitis	0.00177	0.0196	CbGeAlD
Carvedilol—NDUFC2—trigeminal ganglion—periodontitis	0.00174	0.0191	CbGeAlD
Carvedilol—HIF1A—connective tissue—periodontitis	0.00171	0.0188	CbGeAlD
Carvedilol—VCAM1—epithelium—periodontitis	0.00168	0.0186	CbGeAlD
Carvedilol—GJA1—connective tissue—periodontitis	0.00166	0.0183	CbGeAlD
Carvedilol—HIF1A—epithelium—periodontitis	0.00162	0.0179	CbGeAlD
Carvedilol—VEGFA—trigeminal ganglion—periodontitis	0.00158	0.0174	CbGeAlD
Carvedilol—GJA1—epithelium—periodontitis	0.00157	0.0173	CbGeAlD
Carvedilol—ADRB3—connective tissue—periodontitis	0.00152	0.0167	CbGeAlD
Carvedilol—NDUFC2—epithelium—periodontitis	0.00137	0.0151	CbGeAlD
Carvedilol—Bevantolol—ADRB1—periodontitis	0.00122	0.36	CrCbGaD
Carvedilol—Bopindolol—ADRB1—periodontitis	0.00113	0.333	CrCbGaD
Carvedilol—ADRA1D—epithelium—periodontitis	0.000811	0.00894	CbGeAlD
Carvedilol—PTGS1—endothelium—periodontitis	0.000744	0.0082	CbGeAlD
Carvedilol—CYP1A1—mouth—periodontitis	0.000653	0.0072	CbGeAlD
Carvedilol—ADRB1—connective tissue—periodontitis	0.000621	0.00684	CbGeAlD
Carvedilol—Propafenone—ADRB1—periodontitis	0.000618	0.182	CrCbGaD
Carvedilol—KCNH2—trigeminal ganglion—periodontitis	0.000571	0.00629	CbGeAlD
Carvedilol—ADRA2C—trigeminal ganglion—periodontitis	0.000563	0.00621	CbGeAlD
Carvedilol—ADRA2C—parotid gland—periodontitis	0.000531	0.00586	CbGeAlD
Carvedilol—ADRA1A—epithelium—periodontitis	0.000466	0.00514	CbGeAlD
Carvedilol—CYP1A1—parotid gland—periodontitis	0.000455	0.00501	CbGeAlD
Carvedilol—ADRA2A—trigeminal ganglion—periodontitis	0.000449	0.00496	CbGeAlD
Carvedilol—Propranolol—ADRB1—periodontitis	0.000423	0.125	CrCbGaD
Carvedilol—CYP1A1—epithelium—periodontitis	0.00038	0.00419	CbGeAlD
Carvedilol—ADRA2A—connective tissue—periodontitis	0.000373	0.00411	CbGeAlD
Carvedilol—PTGS1—connective tissue—periodontitis	0.000352	0.00388	CbGeAlD
Carvedilol—PTGS1—epithelium—periodontitis	0.000334	0.00368	CbGeAlD
Carvedilol—ABCB1—trigeminal ganglion—periodontitis	0.00025	0.00276	CbGeAlD
Carvedilol—ABCB1—epithelium—periodontitis	0.000197	0.00218	CbGeAlD
Carvedilol—ADRA1A—GPCR downstream signaling—ADRB1—periodontitis	1.84e-05	0.000161	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CXCL3—periodontitis	1.84e-05	0.000161	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—NOS2—periodontitis	1.83e-05	0.00016	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	1.82e-05	0.00016	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—IL6—periodontitis	1.82e-05	0.00016	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—CCL2—periodontitis	1.81e-05	0.000159	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—TGFB1—periodontitis	1.8e-05	0.000158	CbGpPWpGaD
Carvedilol—XDH—Metabolism—PPARA—periodontitis	1.79e-05	0.000156	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—VIP—periodontitis	1.77e-05	0.000155	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—TGFB1—periodontitis	1.76e-05	0.000155	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—VIP—periodontitis	1.75e-05	0.000153	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—VIP—periodontitis	1.73e-05	0.000151	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CXCR2—periodontitis	1.73e-05	0.000151	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—CXCL8—periodontitis	1.73e-05	0.000151	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—MMP3—periodontitis	1.72e-05	0.000151	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—CCL2—periodontitis	1.72e-05	0.000151	CbGpPWpGaD
Carvedilol—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	1.72e-05	0.000151	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CCR2—periodontitis	1.72e-05	0.00015	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—ADRB1—periodontitis	1.71e-05	0.00015	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ACP5—periodontitis	1.71e-05	0.00015	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—NTRK1—periodontitis	1.68e-05	0.000147	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—MMP9—periodontitis	1.68e-05	0.000147	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—TNF—periodontitis	1.68e-05	0.000147	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—NTRK1—periodontitis	1.68e-05	0.000147	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CCR2—periodontitis	1.68e-05	0.000147	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	1.67e-05	0.000147	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—ADRB1—periodontitis	1.67e-05	0.000146	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—MMP1—periodontitis	1.65e-05	0.000144	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	1.64e-05	0.000144	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—VIP—periodontitis	1.64e-05	0.000143	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—CCL2—periodontitis	1.61e-05	0.000141	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—VIP—periodontitis	1.61e-05	0.000141	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SLC52A3—periodontitis	1.6e-05	0.00014	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CXCR2—periodontitis	1.58e-05	0.000138	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—CXCL8—periodontitis	1.57e-05	0.000138	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—MMP3—periodontitis	1.57e-05	0.000138	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ACP5—periodontitis	1.57e-05	0.000138	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MMP3—periodontitis	1.56e-05	0.000137	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MMP3—periodontitis	1.56e-05	0.000137	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CXCR2—periodontitis	1.56e-05	0.000137	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—CXCL8—periodontitis	1.56e-05	0.000137	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CCR2—periodontitis	1.56e-05	0.000137	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—MMP3—periodontitis	1.56e-05	0.000136	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	1.55e-05	0.000136	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—ADRB1—periodontitis	1.55e-05	0.000136	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CXCR2—periodontitis	1.54e-05	0.000135	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—CXCL8—periodontitis	1.54e-05	0.000135	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—MMP3—periodontitis	1.54e-05	0.000135	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—periodontitis	1.53e-05	0.000134	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—CXCL8—periodontitis	1.5e-05	0.000131	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—CCL2—periodontitis	1.5e-05	0.000131	CbGpPWpGaD
Carvedilol—HIF1A—Disease—IL6—periodontitis	1.49e-05	0.000131	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—NOS2—periodontitis	1.48e-05	0.00013	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ACP5—periodontitis	1.48e-05	0.00013	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CXCR2—periodontitis	1.46e-05	0.000128	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—CXCL8—periodontitis	1.46e-05	0.000128	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—MMP3—periodontitis	1.45e-05	0.000127	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CXCR2—periodontitis	1.43e-05	0.000126	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—CXCL8—periodontitis	1.43e-05	0.000126	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—MMP3—periodontitis	1.43e-05	0.000125	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—VIP—periodontitis	1.43e-05	0.000125	CbGpPWpGaD
Carvedilol—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	1.43e-05	0.000125	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—TGFB1—periodontitis	1.39e-05	0.000121	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	1.38e-05	0.000121	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—CXCL8—periodontitis	1.36e-05	0.000119	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—IL6—periodontitis	1.36e-05	0.000119	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CCR2—periodontitis	1.34e-05	0.000118	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—ADRB1—periodontitis	1.34e-05	0.000117	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—VIP—periodontitis	1.33e-05	0.000116	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.32e-05	0.000116	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CXCR2—periodontitis	1.27e-05	0.000112	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—CXCL8—periodontitis	1.27e-05	0.000112	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—MMP3—periodontitis	1.27e-05	0.000111	CbGpPWpGaD
Carvedilol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	1.27e-05	0.000111	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC52A3—periodontitis	1.24e-05	0.000108	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCR2—periodontitis	1.22e-05	0.000107	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.22e-05	0.000107	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCR2—periodontitis	1.21e-05	0.000106	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ADRB1—periodontitis	1.21e-05	0.000106	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCR2—periodontitis	1.2e-05	0.000105	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ADRB1—periodontitis	1.19e-05	0.000105	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	1.19e-05	0.000104	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CXCR2—periodontitis	1.18e-05	0.000104	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—CXCL8—periodontitis	1.18e-05	0.000104	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ACP5—periodontitis	1.18e-05	0.000104	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—MMP3—periodontitis	1.18e-05	0.000104	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	1.18e-05	0.000103	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—GGT1—periodontitis	1.17e-05	0.000103	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—GGT1—periodontitis	1.17e-05	0.000102	CbGpPWpGaD
Carvedilol—XDH—Metabolism—PTGS2—periodontitis	1.16e-05	0.000102	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCR2—periodontitis	1.13e-05	9.93e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ADRB1—periodontitis	1.13e-05	9.89e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—CCL2—periodontitis	1.12e-05	9.83e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCR2—periodontitis	1.12e-05	9.78e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ACP5—periodontitis	1.11e-05	9.76e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ADRB1—periodontitis	1.11e-05	9.73e-05	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	1.11e-05	9.73e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ACP5—periodontitis	1.1e-05	9.67e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NTRK1—periodontitis	1.1e-05	9.6e-05	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—IL6—periodontitis	1.04e-05	9.15e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—TGFB1—periodontitis	1.04e-05	9.11e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CCL2—periodontitis	1.02e-05	8.95e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MMP3—periodontitis	1.02e-05	8.93e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CCL2—periodontitis	1.02e-05	8.91e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CCL2—periodontitis	1.01e-05	8.89e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CCL2—periodontitis	1.01e-05	8.87e-05	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	1e-05	8.8e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CCL2—periodontitis	9.99e-06	8.76e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NTRK1—periodontitis	9.98e-06	8.75e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCR2—periodontitis	9.91e-06	8.68e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NTRK1—periodontitis	9.89e-06	8.67e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	9.87e-06	8.65e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ADRB1—periodontitis	9.87e-06	8.65e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NTRK1—periodontitis	9.77e-06	8.56e-05	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—CXCL8—periodontitis	9.76e-06	8.55e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—TGFB1—periodontitis	9.71e-06	8.51e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GGT1—periodontitis	9.51e-06	8.33e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CCL2—periodontitis	9.46e-06	8.29e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ACP5—periodontitis	9.43e-06	8.27e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CCL2—periodontitis	9.31e-06	8.16e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MMP3—periodontitis	9.28e-06	8.13e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NTRK1—periodontitis	9.24e-06	8.1e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCR2—periodontitis	9.21e-06	8.07e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MMP3—periodontitis	9.2e-06	8.06e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—FGF2—periodontitis	9.19e-06	8.05e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—FGF2—periodontitis	9.17e-06	8.04e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ADRB1—periodontitis	9.17e-06	8.03e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NTRK1—periodontitis	9.1e-06	7.97e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MMP3—periodontitis	9.08e-06	7.96e-05	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—CXCL8—periodontitis	8.9e-06	7.79e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—CXCL8—periodontitis	8.87e-06	7.77e-05	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—CXCL8—periodontitis	8.81e-06	7.72e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GGT1—periodontitis	8.73e-06	7.65e-05	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—CXCL8—periodontitis	8.7e-06	7.62e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	8.6e-06	7.54e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MMP3—periodontitis	8.59e-06	7.53e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MMP3—periodontitis	8.46e-06	7.41e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	8.43e-06	7.39e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PPARA—periodontitis	8.38e-06	7.34e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PPARA—periodontitis	8.36e-06	7.33e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CCL2—periodontitis	8.27e-06	7.24e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—CXCL8—periodontitis	8.23e-06	7.21e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GGT1—periodontitis	8.23e-06	7.21e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—CXCL8—periodontitis	8.1e-06	7.1e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NTRK1—periodontitis	8.08e-06	7.08e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CXCL8—periodontitis	8.08e-06	7.08e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CXCL8—periodontitis	8.04e-06	7.04e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CXCL8—periodontitis	8.02e-06	7.03e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CXCL8—periodontitis	8e-06	7.01e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CXCL8—periodontitis	7.9e-06	6.92e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TGFB1—periodontitis	7.89e-06	6.91e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CCL2—periodontitis	7.68e-06	6.73e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—IL6—periodontitis	7.65e-06	6.7e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MMP3—periodontitis	7.51e-06	6.58e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NTRK1—periodontitis	7.51e-06	6.58e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CXCL8—periodontitis	7.48e-06	6.55e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CXCL8—periodontitis	7.36e-06	6.45e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ACP5—periodontitis	7.28e-06	6.38e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MMP9—periodontitis	7.27e-06	6.37e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MMP9—periodontitis	7.26e-06	6.36e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—CXCL8—periodontitis	7.2e-06	6.31e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MMP3—periodontitis	6.98e-06	6.11e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PPARA—periodontitis	6.8e-06	5.96e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CXCL8—periodontitis	6.69e-06	5.86e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CCL2—periodontitis	6.62e-06	5.8e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GGT1—periodontitis	6.57e-06	5.76e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CXCL8—periodontitis	6.54e-06	5.73e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	6.42e-06	5.62e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PPARA—periodontitis	6.25e-06	5.47e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GGT1—periodontitis	6.19e-06	5.43e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GGT1—periodontitis	6.14e-06	5.38e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CXCL8—periodontitis	6.07e-06	5.32e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCL2—periodontitis	6.04e-06	5.29e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TGFB1—periodontitis	5.99e-06	5.25e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGF2—periodontitis	5.99e-06	5.25e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCL2—periodontitis	5.98e-06	5.24e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TGFB1—periodontitis	5.98e-06	5.24e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCL2—periodontitis	5.9e-06	5.17e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PPARA—periodontitis	5.89e-06	5.16e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCL2—periodontitis	5.59e-06	4.9e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCL2—periodontitis	5.5e-06	4.82e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	5.48e-06	4.8e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGF2—periodontitis	5.45e-06	4.78e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTGS2—periodontitis	5.45e-06	4.77e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTGS2—periodontitis	5.44e-06	4.76e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGF2—periodontitis	5.4e-06	4.74e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGF2—periodontitis	5.34e-06	4.68e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GGT1—periodontitis	5.25e-06	4.6e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CXCL8—periodontitis	5.24e-06	4.59e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGF2—periodontitis	5.05e-06	4.42e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL6—periodontitis	4.98e-06	4.36e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGF2—periodontitis	4.97e-06	4.35e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCL2—periodontitis	4.88e-06	4.28e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CXCL8—periodontitis	4.77e-06	4.18e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MMP9—periodontitis	4.74e-06	4.15e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CXCL8—periodontitis	4.73e-06	4.14e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PPARA—periodontitis	4.7e-06	4.12e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CXCL8—periodontitis	4.67e-06	4.09e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—periodontitis	4.54e-06	3.98e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCL2—periodontitis	4.54e-06	3.98e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—periodontitis	4.52e-06	3.96e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—periodontitis	4.51e-06	3.95e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—periodontitis	4.5e-06	3.94e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—periodontitis	4.44e-06	3.89e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARA—periodontitis	4.43e-06	3.88e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGS2—periodontitis	4.42e-06	3.88e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CXCL8—periodontitis	4.42e-06	3.87e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGF2—periodontitis	4.41e-06	3.87e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARA—periodontitis	4.4e-06	3.85e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CXCL8—periodontitis	4.35e-06	3.81e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MMP9—periodontitis	4.32e-06	3.78e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MMP9—periodontitis	4.28e-06	3.75e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MMP9—periodontitis	4.22e-06	3.7e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—periodontitis	4.2e-06	3.68e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—periodontitis	4.13e-06	3.62e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGF2—periodontitis	4.1e-06	3.59e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGS2—periodontitis	4.06e-06	3.56e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GGT1—periodontitis	4.05e-06	3.55e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MMP9—periodontitis	3.99e-06	3.5e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MMP9—periodontitis	3.93e-06	3.45e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TGFB1—periodontitis	3.9e-06	3.42e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CXCL8—periodontitis	3.86e-06	3.38e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGS2—periodontitis	3.83e-06	3.36e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARA—periodontitis	3.76e-06	3.29e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—periodontitis	3.67e-06	3.22e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CXCL8—periodontitis	3.59e-06	3.14e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TGFB1—periodontitis	3.56e-06	3.12e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TGFB1—periodontitis	3.52e-06	3.09e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MMP9—periodontitis	3.49e-06	3.06e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TGFB1—periodontitis	3.48e-06	3.05e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—periodontitis	3.41e-06	2.99e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TGFB1—periodontitis	3.29e-06	2.88e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MMP9—periodontitis	3.24e-06	2.84e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TGFB1—periodontitis	3.24e-06	2.84e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS2—periodontitis	3.06e-06	2.68e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—periodontitis	2.94e-06	2.58e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARA—periodontitis	2.9e-06	2.54e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS2—periodontitis	2.88e-06	2.53e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TGFB1—periodontitis	2.88e-06	2.52e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS2—periodontitis	2.86e-06	2.5e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—periodontitis	2.68e-06	2.35e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TGFB1—periodontitis	2.67e-06	2.34e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—periodontitis	2.66e-06	2.33e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—periodontitis	2.62e-06	2.3e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—periodontitis	2.48e-06	2.17e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS2—periodontitis	2.44e-06	2.14e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—periodontitis	2.44e-06	2.14e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—periodontitis	2.17e-06	1.9e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—periodontitis	2.02e-06	1.77e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS2—periodontitis	1.88e-06	1.65e-05	CbGpPWpGaD
